Cancer research
Breakthrough Blood Test Expands Access and Reduces Costs for Lung Cancer Screening
A new study abstract co-authored by healthcare economist Jennifer Hinkel, M.Sc., projects that Cizzle Bio's proprietary CIZ1B biomarker blood test for early-stage lung cancer could save the U.S. Medicare program up to $518 million annually. The study models how integrating CIZ1B into lung cancer screening for